NASDAQ:HSGX - Histogenics Corporation
$0.13
 $-0.00
-2.69%
4:20PM EDT
2019-02-22
Histogenics Corporation is a regenerative medicine company. The Company is focused on developing and commercializing products in the musculoskeletal segment of the marketplace. The Company's product candidate, NeoCart utilizes various aspects of regenerative medicine platform to develop a tissue implant intended to treat tissue injury in the field of orthopedics, specifically cartilage damage in the knee. NeoCart is a cartilage-like implant created using a patient's own cartilage cells through a series of tissue engineering processes. The patient's cells are separated from a tissue biopsy specimen extracted from the patient and multiplied in its laboratory. The cells are then infused into its scaffold that provides structure for the developing implant. Before NeoCart is implanted in a patient, the cell- and scaffold construct undergoes a bioengineering process in the Company's Tissue Engineering Processor (TEP). The Company has operations in the United States and Israel. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  HSGX     avg for
industry  
  avg for
sector  
42 stocks weight:  -1000. 00 M 0. 00   0. 00  
42 stocks rank:  4. 12 K 2. 00 K 1. 08 K
# analyst opinions:  1. 00   14. 68   14. 18  
mean recommendation:  2. 00   1. 96   1. 94  

quick ratio:  0. 58   5. 17   1. 75  
current ratio:  0. 67   5. 48   2. 10  

target price low:  0. 16   90. 05   118. 16  
target price avg:  0. 16   115. 98   142. 03  
target price high:  0. 16   141. 44   162. 86  
1-yr high:  3. 04   124. 28   143. 16  
last close:  0. 13   102. 75   129. 63  
50-day avg:  0. 21   98. 90   122. 76  
200-day avg:  1. 28   100. 04   123. 17  
1-yr low:  0. 09   78. 22   100. 14  
volume:  3. 05 M 2. 36 M 4. 94 M
50-day avg volume:  10. 10 M 3. 14 M 4. 85 M
200-day avg volume:  4. 26 M 3. 12 M 4. 26 M

1-day return:  0. 00 % 1. 74 % 0. 96 %
this week return:  0. 00 % -0. 72 % -0. 25 %
12-wk return:  -69. 63 % 1. 23 % -0. 75 %
52-wk return:  -94. 95 % -2. 03 % 16. 23 %

enterprise value (EV):  2. 88 M 54. 82 B 107. 48 B
market cap:  8. 26 M 47. 12 B 97. 54 B
EBITDA:  -25. 68 M 4. 72 B 7. 18 B
enterprise multiple (EV/EBITDA):  -0. 11   9. 03   16. 84  
total debt:  0. 00   13. 41 B 16. 70 B
net income (common):  -13. 78 M 2. 34 B 3. 61 B

shares outstanding:  62. 03 M 594. 48 M 1. 22 B
shares:  49. 62 M 592. 96 M 1. 15 B
shares short:  2. 95 M 10. 54 M 11. 92 M
shares short prior month:  4. 48 M 11. 90 M 11. 87 M
short ratio:  0. 22   4. 86   3. 18  
short % of float:  25. 73 % 6. 23 % 2. 78 %
total cash/share:  0. 08   11. 99   10. 04  
total cash:  5. 19 M 7. 30 B 7. 05 B
free cash flow:  -10. 49 M 176. 15 M 2. 43 B
operating cash flow:  -13. 16 M 277. 94 M 3. 06 B

book value:  -0. 28   15. 06   28. 80  
price/book:  -0. 47   -0. 58   -2. 51  
operating margins:  0. 00 % -466. 96 % -635. 17 %
EBITDA margins:  0. 00 % 13. 54 % 22. 51 %
profit margins:  0. 00 % 6. 67 % 10. 02 %
gross margins:  0. 00 % 48. 21 % 54. 28 %

1-yr max volatility:  -72. 56 % --- ---
1-yr mean volatility:  -0. 40 % 0. 01 % 0. 07 %

1-yr EPS:  -0. 95   3. 08   4. 11  
forward EPS:  -0. 22   4. 75   7. 18  
P/E:  -0. 14   15. 54   29. 27  
forward P/E:  -0. 59   -20. 90   3. 33  
PE/G:  0. 00   1. 33   6. 07  
growth:  -85. 09 % 755. 42 % 114. 65 %
earnings high:  -0. 06   1. 33   1. 68  
earnings avg:  -0. 09   0. 97   1. 54  
earnings low:  -0. 12   0. 70   1. 41  
revenue high:  -0. 00   2. 81 B 11. 37 B
revenue avg:  -0. 00   2. 70 B 11. 06 B
revenue low:  -0. 00   2. 61 B 10. 84 B
return on assets:  -123. 55 % -3. 63 % 3. 73 %

beta (1yr vs S&P500):  0. 76   1. 22   0. 94  
sharpe (1yr):  -0. 59   0. 14   1. 05  

held % insiders:  9. 83 % 6. 40 % 3. 16 %
held % institutions:  14. 66 % 79. 62 % 70. 81 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-02-22 : HSGX
.        + 0 =             0 :: INITIAL WEIGHT
.  + 345.472 =       345.472 :: inverse volume-to-price addition
.  + 265.644 =       611.116 :: spline projection addition
.  - 292.377 =        318.74 :: poor performance penalty
.    x 0.413 =       131.779 :: one-year gains+dividend factor
.    x 0.904 =       119.146 :: 13 weeks' performance factor
.    x 1.478 =       176.091 :: industry recommendation factor
.    x 2.068 =       364.235 :: symbol recommendation factor
.    x 0.988 =       359.735 :: return on assets factor
.    x 2.123 =       763.619 :: current ratio factor
.    x 1.595 =      1218.175 :: quick ratio factor
.    x 2.041 =       2486.87 :: short ratio factor
.    x 1.995 =      4962.027 :: price-to-book factor
.    x 2.175 =     10793.905 :: P/E weight
.    x 2.209 =     23843.295 :: PE/G factor
.    x 1.578 =     37621.927 :: beta factor
.    x 0.588 =     22115.319 :: sharpe factor
.    x 1.491 =     32964.719 :: target low factor
.    x 1.158 =     38168.423 :: target mean factor
.    x 1.047 =     39975.966 :: target high factor
.    x 1.012 =     40468.149 :: industry 12-weeks return
.    x 0.987 =     39957.364 :: overall "drift" factor
.    x 0.997 =     39818.636 :: largest single-day jump factor
.    x 0.059 =      2335.404 :: low price factor
.      x 1.0 =      2335.162 :: factor hist industry gain for week 07
.   cubeRoot =        13.267 :: reduced for readability
. -999999999.999 zero/no returns for 20 days out of the past 42x trading days
.                  -999999999.999 :: FINAL WEIGHT for NASDAQ:HSGX


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org